论文部分内容阅读
目的探讨尤瑞克林联合依达拉奉治疗进展性脑梗死疗效及对神经元特异性烯醇化酶(NSE)的影响,探讨尤瑞克林对脑的保护作用。方法利用酶联免疫吸附法检测109例急性进展性脑梗死患者尤瑞克林联合依达拉奉(观察组)治疗过程中血清NSE水平,采用美国国立卫生院神经功能缺损评分量表(NIHSS)评定神经功能缺损程度,并与依达拉奉组(对照组)进行比较。结果观察组治疗后第7天血清NSE水平开始下降,低于常规治疗组(P<0.05);观察组NIHSS在治疗后第7、14天时明显低于对照组(P<0.05)。结论尤瑞克林对脑神经元有保护作用,能更快更有效地改善急性进展性脑梗死患者的神经功能缺损。
Objective To investigate the curative effect of norepinephrine combined with edaravone in patients with progressive cerebral infarction and its effect on neuron specific enolase (NSE), and to explore the protective effect of uracil against edaravone. Methods The levels of serum NSE in 109 patients with acute progressive cerebral infarction treated with uracil and edaravone (observation group) were detected by enzyme linked immunosorbent assay (ELISA). The neurological deficit scale (NIHSS) The degree of neurological deficit was assessed and compared with edaravone (control group). Results The level of NSE in observation group began to decline on the 7th day after treatment, which was lower than that of the routine treatment group (P <0.05). NIHSS in the observation group was significantly lower than that of the control group on the 7th and 14th days after treatment (P <0.05). Conclusion Urelin can protect neurons from neurological deficits in patients with acute progressive cerebral infarction more rapidly and effectively.